|
KMID : 0361620230580060485
|
|
Journal of the Korean Orthopaedic Association
2023 Volume.58 No. 6 p.485 ~ p.490
|
|
|
Current Issues on Denosumab Use in Giant Cell Tumor of Bone
|
|
Joo Min-Wook
Cho Yoon-Joo
|
|
|
Abstract
|
|
|
|
Since the FDA (U.S. Food and Drug Administration) approved the use of denosumab for giant cell tumor of bone in 2013, it has been applied preoperatively or in unresectable cases, and research on its effects, complications, and appropriate cessation has been active. Accordingly, the authors review the current issues of denosumab use in giant cell tumor of bone.
|
|
|
KEYWORD
|
|
|
giant cell tumor of bone, denosumab
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|